GEA
BHVN

Glen Eagle Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Glen Eagle Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33
Closed -$4.99K – 1191
2022
Q3 		$4.99K Buy
+33
New +$4.99K ﹤0.01% 707